Laboratory Corporation of America Holdings

Equities

LH

US50540R4092

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-03-27 pm EDT 5-day change 1st Jan Change
216.6 USD +1.43% Intraday chart for Laboratory Corporation of America Holdings +3.44% -4.72%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Markets Steady -2- DJ
Argus Upgrades Laboratory Corp of America Holdings to Buy From Hold, Price Target is $250 MT
Laboratory Corp of America Launches PTau217 Diagnostic Test for Alzheimer's Disease MT
Labcorp Introduces New Biomarker Test for Alzheimer's Disease MT
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials CI
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-Targeted Therapies for Patients with Epithelial Ovarian Cancer CI
Laboratory Corp Of America Holdings Insider Sold Shares Worth $1,102,736, According to a Recent SEC Filing MT
Labcorp Launches Weight Loss Management Testing Solutions CI
Pinnacle Fertility Partners with Labcorp to Advance Genetic Testing Services CI
Leerink Partners Initiates Coverage on Laboratory Corp of America With Outperform Rating, $260 Price Target MT
Laboratory Corp Of America Holdings Insider Sold Shares Worth $7,451,866, According to a Recent SEC Filing MT
Deutsche Bank Raises Laboratory Corp of America Price Target to $220 From $215, Maintains Hold Rating MT
Laboratory Corporation of America Holdings to Seek Acquisitions CI
Transcript : Laboratory Corporation of America Holdings, Q4 2023 Earnings Call, Feb 15, 2024
Laboratory Corp of America Holdings' Q4 Adjusted Earnings, Revenue Rise; 2024 Adjusted Earnings Outlook Issued MT
Tranche Update on Laboratory Corporation of America Holdings (NYSE:LH)'s Equity Buyback Plan announced on December 9, 2021. CI
Laboratory Corporation of America Holdings Announces Quarterly Cash Dividend, Payable on March 13, 2024 CI
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Posts Q4 Revenue $3.03B, vs. Street Est of $3.02B MT
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Posts Q4 EPS $3.30, vs. Street Est of $3.26 MT
Laboratory Corporation of America Holdings Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Tech-led U.S. 'exceptionalism' underlined RE
Evercore ISI Initiates Laboratory Corp of America Holdings at In-Line Rating With $240 Price Target MT
Laboratory Corp of America Rolls Out Test for Blood Pressure Disorder in Pregnant Women MT
Labcorp Launches New Test For Risk Assessment, Prognosis Of Severe Preeclampsia In Pregnant Women RE
Labcorp Announces the Launch and Availability of A New, FDA-Cleared Blood Test for Risk Assessment and Clinical Management of Severe Preeclampsia CI
Chart Laboratory Corporation of America Holdings
More charts
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
216.6 USD
Average target price
244.9 USD
Spread / Average Target
+13.07%
Consensus
  1. Stock
  2. Equities
  3. Stock Laboratory Corporation of America Holdings - Nyse
  4. News Laboratory Corporation of America Holdings
  5. Laboratory of America : OmniSeq Launch Genomic, Immune Profiling Test OmniSeq INSIGHT